Literature DB >> 942269

Thrombocytosis in rheumatoid arthritis.

R M Hutchinson, P Davis, M I Jayson.   

Abstract

Of 75 patients with rheumatoid arthritis, 39 had a thrombocytosis and 36 normal platelet count. A highly significant relationship existed between the platelet count and disease severity and an inverse correlation with level of haemoglobin. An association appeared to exist between thrombocytosis and extra-articular manifestations of rheumatoid disease. By 75Selenomethionine labelling platelet and fibrinogen survival and turnover were determined. In 3 rheumatoid patients with thrombocytosis platelet survival was decreased and turnover increased. In these and a further rheumatoid patient with a normal platelet count there was reduced fibrinogen survival and increased fibrinogen turnover, and in addition excess fibrin degradation products were detected. The results suggest that thrombocytosis accompanies the more severe cases of rheumatoid disease and is due to a compensatory increase in platelet production associated with active intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942269      PMCID: PMC1006524          DOI: 10.1136/ard.35.2.138

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

Review 2.  Thrombopoietin.

Authors:  S Ebbe
Journal:  Blood       Date:  1974-10       Impact factor: 22.113

3.  Fibrin degradation products in rheumatoid arthritis.

Authors:  R M Bennett; A C Eddie-Quartey; P J Holt
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

4.  Thrombocytes in fibrinogen-induced arthritis in rabbits.

Authors:  O Selroos; O Wegelius
Journal:  Scand J Rheumatol       Date:  1973       Impact factor: 3.641

5.  Rheumatoid synovitis. An extravascular immune complex disease.

Authors:  N J Zvaifler
Journal:  Arthritis Rheum       Date:  1974 May-Jun

6.  Platelet and fibrinogen kinetics with ( 75 Se)-selenomethionine in patients with myeloproliferative disorders.

Authors:  I Brodsky; E M Ross; G Petkov; S B Kahn
Journal:  Br J Haematol       Date:  1972-02       Impact factor: 6.998

7.  Thrombocytosis in rheumatoid arthritis.

Authors:  O Selroos
Journal:  Scand J Rheumatol       Date:  1972       Impact factor: 3.641

8.  Platelet and fibrinogen kinetics with ( 75 Se)selenomethionine in thrombocytopenic states. II.

Authors:  I Brodsky; E M Ross; S B Kahn; G Petkov
Journal:  Br J Haematol       Date:  1972-05       Impact factor: 6.998

9.  Use of the megathrombocyte as an index of megakaryocyte number.

Authors:  S K Garg; E L Amorosi; S Karpatkin
Journal:  N Engl J Med       Date:  1971-01-07       Impact factor: 91.245

10.  The effect of acetylsalicyclic acid on platelet function.

Authors:  G Evans; M A Packham; E E Nishizawa; J F Mustard; E A Murphy
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  20 in total

1.  Immunohistological analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis.

Authors:  M Soden; M Rooney; A Whelan; C Feighery; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity.

Authors:  M G Grimaldi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  D Thomas; A S Gallus; P M Brooks; R Tampi; R Geddes; W Hill
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

4.  Anticardiolipin antibodies in patients with rheumatoid arthritis.

Authors:  A J de Brum-Fernandes; W Cossermelli-Messina; C Bueno; M Barreto Santiago; W Weidebach; W Cossermelli; R M de Oliveira
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

5.  Myelotoxicity of D-penicillamine.

Authors:  A G Kay
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

6.  Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.

Authors:  H J Williams; J R Ward; M J Egger; J C Reading; C O Samuelson; M Altz-Smith; R W Willkens; M A Solsky; S P Hayes; D Furst
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

7.  Thrombocytosis in rheumatoid arthritis. Recurrent arterial thromboembolism and death.

Authors:  M Ehrenfeld; S Penchas; M Eliakim
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

8.  Platelets in the synovial fluid of patients with rheumatoid arthritis.

Authors:  M Farr; A Wainwright; M Salmon; C A Hollywell; P A Bacon
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

9.  Measurement of haematological indices of chronic rheumatic disease with two newer generation automated systems, the H1 and H6000 (Technicon).

Authors:  L Turner-Stokes; D Jones; K G Patterson; A Todd-Pokropek; D A Isenberg; A H Goldstone
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

10.  Thrombocytosis of active rheumatoid disease.

Authors:  M Farr; D L Scott; T J Constable; R J Hawker; C F Hawkins; J Stuart
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.